Company / Financials
Vivani Medical, Inc. Financials
FY2015-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$8.9M
FY2017 · +163.2% YoY
Net Income
-$20.0M
FY2017 · +43.1% YoY
Profit Margin
-223.7%
FY2017 · net income / revenue
ROE
-98.8%
FY2017 · return on equity
Total Assets
$14.5M
FY2017
Total Debt
-
FY2017
Equity
$20.3M
FY2017
ROA
-138.1%
FY2017 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$8.9M+163.2% YoYNet Income HistoryProfit after all expenses and taxes-$20.0M+43.1% YoYGross Profit HistoryRevenue minus cost of goods sold$3.7M+2385.6% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$5.3M+48.8% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$20.0M+5.6% YoYSG&A Expense HistorySelling, general, and administrative expenses$8.2M+25.3% YoYR&D Expense HistoryResearch and development spending$3.0M-39.8% YoYInterest Expense HistoryCost of borrowing and debt obligations$8.0KEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$0.56+60.3% YoYShares Outstanding HistoryWeighted average diluted shares outstanding42.7M+170342.7% YoY